Working… Menu

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02375204
Recruitment Status : Recruiting
First Posted : March 2, 2015
Last Update Posted : October 12, 2021
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Movember Foundation
Institute of Cancer Research (ICR), United Kingdom
Cancer Research UK
Irish Group CTI
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2024
Study Completion Date : No date given